Click here for YNHH home page.


Sign up for HealthLINK.

Can we help?

Follow up on this month's He@lthLINK

 


Search this site for:






Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202



Search this site for:








Yale-New Haven Hospital, New Haven, Connecticut, USA HealthLINK: Women's Health
May 29, 2003

News this month
Channel blocker helps Raynaud’s sufferers

People who get icy cold fingers and toes may have more than just an aversion to cold weather.

Experts estimate Raynaud’s disease affects 5-10 % of the population.

When normal, healthy people are in a cold environment, the tiny blood vessels in their skin naturally constrict in an effort to conserve heat. For those with Raynaud's disease, which some experts estimate affects 5 to 10 percent of the population, that natural response becomes extreme. The blood vessels constrict and go into spasm, reducing the blood flow to those areas. Affected areas turn white from lack of blood or blue from lack of oxygen.

This response is seen most often in the fingers and toes, but it also can occur in the ears, cheeks and nose. And, in some people with the disorder, the constriction also can occur in response to emotional stress.

Approximately 75 % of all cases are diagnosed in women 15 to 40 years old.

Primary or secondary
Raynaud’s phenomenon can occur on its own, or it can be secondary to another condition such as scleroderma or lupus.

Most people who have Raynaud’s phenomenon have the primary form (the milder version). A person who has primary Raynaud’s phenomenon has no underlying disease or associated medical conditions.

More women than men are affected, and approximately 75 percent of all cases are diagnosed in women who are between 15 and 40 years old. It appears to be more common in people who live in colder climates; however, people with the disorder who live in milder climates may have more attacks during periods of colder or damp weather.

Although secondary Raynaud’s phenomenon is less common than the primary form, it is often more serious. Secondary means that patients have an underlying disease or condition that causes Raynaud’s phenomenon. Connective tissue diseases are among the most common causes. Some of these diseases reduce blood flow to the digits by causing blood vessel walls to thicken and the vessels to constrict too easily.

Raynaud’s phenomenon is seen in approximately 85 to 95 percent of patients with scleroderma and mixed connective tissue disease, and it is present in about one-third of patients with systemic lupus erythematosus. Raynaud’s phenomenon also can occur in patients who have other connective tissue diseases, including Sjögren’s syndrome, dermatomyositis and polymyositis.

Treatment options studied
A clinical trial was published in the Archives of Internal Medicine that compared the use of a sustained-release calcium channel blocker medication called nifedipine with biofeedback on patients with primary Raynaud’s. The results show nifedipine offers a clear benefit.

Study participants included 313 individuals with primary Raynaud’s disease who reported two or more attacks per day during the previous cold season. Patients were assigned to one of four treatment groups: sustained-release nifedipine, pill placebo, temperature biofeedback or control biofeedback.

Participants taking sustained-release nifedipine reported a 66% reduction in the number of attacks, as well as overall improvement in their symptoms.

Drug vs. biofeedback therapy
After two winters on the sustained-release nifedipine, participants reported a 66 percent reduction in the number of attacks, as well as overall improvement in their symptoms. Although participants in the biofeedback therapy group reported no significant reduction in the number of attacks and no improvement in symptoms, researchers believe further study of this method’s effectiveness would be worthwhile. This would be especially true for patients who could not tolerate vasodilator medications such as nifedipine or those who prefer nondrug treatments.

Fifteen percent of study participants discontinued nifedipine because of reported side effects such as rapid heartbeat, swelling, flushing and headache. There was a lower incidence of these side effects over time.

In addition, the percentage of study volunteers experiencing these side effects from sustained-release nifedipine was significantly lower than for patients in trials that studied immediate-release nifedipine. Participants in previous trials studying immediate-release nifedipine also reported having 50 percent fewer attacks, but immediate-release nifedipine was found to be less effective over time than the sustained release variety.


Heart Advantage.

Physician Referral Online

A free and confidential service
of Yale-New Haven Hospital.

Physician Referral Online
Using your own criteria, you can request information from a database of 900 area physicians who have registered to participate.

Request an appointment
We would be happy to assist you in scheduling an appointment with a member of the hospital's medical staff. Use the link above or call:

203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.


2002 Best Hospital--U.S. News Online

For the 12th year in a row, Yale-New Haven has been highly ranked by U.S. News & World Report for its programs in gynecology.


Janie Evans, MD portrait

Coping with Raynaud’s disease

In a nutshell, Raynaud’s disease is an exaggerated vascular response to cold or stress. Normally, our blood vessels narrow to preserve heat in our body’s core during cold weather, but in those with Raynaud’s, that response doesn’t just slow the amount of blood to fingers and toes, it is drastically reduced.

“Fingers…turn shockingly white from loss of blood or blue from lack of oxygen.”

The result is fingers that turn shockingly white from loss of blood or blue from lack of oxygen. There is clear color demarcation between the affected and nonaffected skin. The fingers or toes may also feel cold and numb. When patients warm up, their fingers often turn bright red.

As the attack ends, throbbing and tingling may occur. An attack can last anywhere from less than a minute to several hours. It occurs most frequently in women and usually makes its first appearance between the ages of 16 and 25.

Diagnosing Raynaud’s disease
We usually diagnose Raynaud’s by listening carefully to how patients describe these attacks. Some physicians try to provoke an attack by dipping hands or feet in ice water, but we can usually determine if a patient is affected by their own description of the symptoms.

“Secondary Raynaud’s is more serious and complex and may be the first clue of an underlying connective tissue disease….”

What’s more difficult initially is determining whether an individual is affected by primary or secondary Raynaud’s. It’s important to determine the type since secondary Raynaud’s is more serious and complex and may be the first clue of an underlying connective tissue disease such as scleroderma or lupus.

Although we don’t yet understand what causes Raynaud’s, there are some potential culprits that need to be ruled out. Some drugs can result in the same vasoconstrictive response, including cocaine, some over-the-counter cold medications and ergot drugs that are used to treat migraine headaches.

Raynaud’s phenomenon can also occur from damage to blood vessels from years of heavy smoking or experience with jarring machinery such as pile drivers.

Primary form more common
The primary form of Raynaud’s is by far the most common. There is no underlying medical condition associated with it and the symptoms are usually relatively mild.

Patients with secondary Raynaud’s, however, have a more aggressive form. Their episodes are more severe and may result in ulcerated tissue and in some cases, loss of fingers or toes.

One test we use to identify secondary Raynaud’s is called nailfold capillaroscopy. During this test, we put a drop of oil on the skin at the base of the patient’s fingernail. We then examine the tiny capillaries in this area under a microscope. If the capillaries are enlarged or deformed, the patient may have a connective tissue disease.

Lifestyle changes help
I usually encourage patients to begin by making lifestyle changes:

  • Remove anything that may be aggravating the disease. Stop smoking; explore substitutes for medications that may be adding to the problem.
  • Exercise, particularly vigorous aerobic exercise, helps many patients.
  • Avoid unnecessary exposure to cold; always wear a hat, warm socks and mittens in cold weather.
  • Many products designed for those who engage in cold-weather sports can be very helpful for Raynaud’s patients, including small chemical heating pouches that can be placed in pockets, mittens, boots or shoes.
  • Air conditioning can trigger attacks. Turning down the air conditioning or wearing a sweater may help.
  • Some people find it helpful to use insulated drinking glasses and to put on gloves before handling frozen or refrigerated foods.

These relatively simple measures are often enough to help those with primary Raynaud’s manage their condition.

Drug therapy
Those with secondary Raynaud’s and some others who need help with symptom control should discuss calcium channel blocker therapy with their physicians. The Annals of Internal Medicine study and others have shown a clear benefit—nearly two-thirds of patients are significantly helped by taking nifedipine.

Although the study comparing nifedipine and biofeedback indicated no improvement with biofeedback therapy, there have been some reports of success. Patients who have side effects such as headaches from nifedipine or who prefer a nondrug solution, might try biofeedback. Biofeedback is a process in which a patient is taught to gain voluntary control over a body process that’s typically nonvoluntary such as blood flow.

When to call a doctor
If you have distinct reversible color changes in your fingers or toes that are like those described above, you should see your doctor to rule out the presence of an underlying disease. If you have been diagnosed with Raynaud’s and develop unusual symptoms such as inflammation or sores or if you are not able to reverse a Raynaud’s attack after rewarming your extremities, call your doctor.


Dr. Evans is a rheumatologist at Yale-New Haven Hospital and an associate professor at the Yale School of Medicine.


Spacer.
Subscribe to HealthLink.

 

Other related links.

Copyright 1999-2008.
Top of Page. Y-NHH. YNHHS. Site Editor.

Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page
Yale-New Haven Medical Center